Spermatogonial stem cells (SSCs) are a special subset of undifferentiated spermatogonia and are the foundation of spermatogenesis. They adhere to the basement membrane of the seminiferous tubule, and undergo repeated self-renewal and differentiation to produce differentiating spermatogonia. These cells further amplify their population by several repeats of mitotic divisions and then enter meiotic division to produce mature spermatozoa \[[@r1]\].

SSCs require a specific microenvironment, often described as a germline niche, to maintain their stem cell activity. Germline niche can be described as 'the microenvironment where SSCs can maintain their undifferentiated state'. Historically and histologically, the basement membrane of the seminiferous tubule was known to form the germline niche \[[@r2]\]. Indeed, a cellular subset located on the basement membrane is enriched in SSCs \[[@r3]\]. Sertoli cells, which are somatic cells within the seminiferous tubules, are also important for SSC function by producing glial cell line-derived neurotrophic factor (GDNF) \[[@r4]\]. Considering that peritubular myoid cells (PMCs) produce GDNF for proper spermatogenesis, PMCs also constitute the germline niche \[[@r5]\]. In 2007, Yoshida *et al.* found that undifferentiated spermatogonia are prone to reside in a region on the basement membrane, which is in proximity to the interstitium that contains Leydig cells and blood vessels \[[@r6]\]. In fact, Hara *et al.* observed the prowling of undifferentiated spermatogonia on the basement membrane near the interstitial tissue containing vasculature \[[@r7]\]. These data suggest that a specialized region of the basement membrane, in the vicinity of Sertoli cells, Leydig cells, and blood vessels, represents the germline niche. Resident macrophages surrounding the seminiferous tubules also act as a niche component by expressing colony-stimulating factor 1 (CSF1), which encodes a cytokine that accelerates SSC self-renewal \[[@r8], [@r9]\]. As described above, the identity of the germline niche is gradually being clarified. However, it is still difficult to identify the actual location of the germline niche, because SSCs might move around in the seminiferous tubules \[[@r7]\].

The germline niche provides factors required for SSC self-renewal. Previous studies have reported that several cytokines, including fibroblast growth factor (FGF) 8, vascular endothelial growth factor A, wingless-type MMTV integration site family (WNT) 3A, WNT5A, and WNT6 contribute to SSC self-renewal or to the proliferation of undifferentiated spermatogonia \[[@r10],[@r11],[@r12],[@r13],[@r14],[@r15]\]. Of other cytokines, GDNF was primarily confirmed to be able to induce SSC self-renewal. Meng *et al.* demonstrated that *Gdnf* transgenic mice exhibited hyperproliferation of undifferentiated spermatogonia, whereas *Gdnf* heterozygous mutant mice gradually lost spermatogenesis presumably due to mitotic arrest \[[@r4]\]. Yomogida *et al.* confirmed that the SSC frequency in *Gdnf* transgenic mouse testes was significantly higher than that in wild-type mouse testes by spermatogonial transplantation assay \[[@r16]\].

GDNF was applied to establish cultured SSC line called germline stem (GS) cells \[[@r17]\]. GS cells can be expanded *in vitro* for more than two years under stimulation with GDNF and FGF2, and can re-initiate spermatogenesis in infertile testes to produce offspring \[[@r18]\]. As reported previously, the frequency of SSCs in undifferentiated type A single spermatogonia is estimated to be 1 in 10 \[[@r19]\]. On the other hand, the SSC frequency in GS cell culture was estimated to be 1--2% or --20% by spermatogonial transplantation or *in vitro* clonal analysis of drug-resistant genes by electroporation \[[@r20],[@r21],[@r22]\], suggesting that both, single spermatogonia *in vivo* and GS cells *in vitro*, possess similar SSC frequency. Moreover, GS cells, undifferentiated spermatogonia, and SSCs require GDNF signals for survival and proliferation/self-renewal \[[@r4], [@r16], [@r17], [@r23]\], suggesting that these cells share common molecular mechanisms with respect to GDNF. Indeed, this culture system has also been applied to evaluate the activity of FGF2, WNT3A, and WNT5A to expand SSCs *in vitro* \[[@r12],[@r13],[@r14], [@r24]\]. These reports suggest that GS cells are useful as an *in vitro* culture model of SSCs and undifferentiated spermatogonia.

Our group identified FGF2 as another SSC self-renewal factor \[[@r24]\]. We succeeded in establishing an SSC line with FGF2 under GDNF-free condition *in vitro*, and designated this line as FGF2-cultured spermatogonia (F-SPG). F-SPG can proliferate *in vitro* for more than 4 months without losing SSC activity and can restore the fertility of infertile *Kit^W^/Kit^W-v^* (W) mouse, demonstrating that FGF2 is also a *bona fide* self-renewal factor \[[@r24]\]. However, our group also found functional differences between FGF2 and GDNF. F-SPG are phenotypically and functionally distinct from GDNF-cultured spermatogonia (G-SPG), in that the stem cell frequency in F-SPG is less than that in G-SPG, and F-SPG exhibit higher expression levels of the receptor tyrosine kinase protein KIT (a marker for differentiating spermatogonia) compared with G-SPG. Moreover, F-SPG and G-SPG exhibit distinct behaviors following PD0325901 (an inhibitor of [m]{.ul}itogen-activated protein kinase (MAPK)/[e]{.ul}xtracellular signal-regulated kinase [k]{.ul}inase (MEK)) treatment. This molecule has been shown to inhibit the survival and proliferation of G-SPG, but not of F-SPG \[[@r24]\]. These data suggest that F-SPG exhibit the characteristics of a more differentiated subset of undifferentiated spermatogonia *in vivo*, compared with G-SPG and GS cells, and that FGF2 plays a role distinct from that of GDNF in the regulation of SSCs and/or undifferentiated spermatogonia in the testis.

To identify the exact role of FGF2 in the testis, it is essential to reveal its molecular function and spatiotemporal expression pattern. Here, we aimed to unveil the role of FGF2 in the testis by comparing its expression dynamics and regulatory mechanisms with those of GDNF.

Materials and Methods {#s1}
=====================

Mice and treatments
-------------------

Male and female C57BL/6NCrSlc (B6) mice at 8 or 52 weeks of age, and male WBB6F1/kit-*Kit^W^*/*Kit^W-v^*/Slc (W) mice at 8 weeks of age were purchased from Japan SLC (Shizuoka, Japan). At 7 days of age, male B6 mice were obtained by intercrossing B6 mice. For busulfan treatment, male B6 mice at 4 or 6 weeks of age were injected intraperitoneally with 44 or 15 mg/kg body weight busulfan, respectively (Sigma-Aldrich, St Louis, MO, USA). Experimental cryptorchidism was performed on 8-week-old male B6 mice, as described by Nishimune *et al.* \[[@r25]\]. Hypophysectomized, thyroidectomized, adrenalectomized, and sham-operated B6 mice were also purchased from Japan SLC; these operations were conducted at 6 weeks of age. For retinoic acid (RA) treatment, all-trans RA (Sigma-Aldrich) was dissolved in a 10% ethanol-sesame oil (Nacalai Tesque, Kyoto, Japan) solution at 3.75 mg/ml and then injected (200 μl) intraperitoneally into 8-week-old B6 mice (750 μg per mouse). All animal experiments were approved by the Institutional Animal Care and Use Committee of Shinshu University (Approval No. 260013 and No. 280120).

Preparation of testicular interstitial cells and seminiferous tubules without germ cells
----------------------------------------------------------------------------------------

For interstitial cell enrichment, seminiferous tubules were collected from the testes of 2-month-old B6 mice treated with 44 mg/kg body weight of busulfan at 4 weeks of age. After detangling, the tubules were digested with 2 mg/ml collagenase type II (Sigma-Aldrich) in Hanks' Balanced Salt Solution (HBSS) (+) (Thermo Fischer Scientific, Waltham, MA, USA) for 10 min at 34°C. After tubule sedimentation, the supernatant containing the testicular interstitial cells was collected and centrifuged to obtain a cell pellet. Tubules without both germ cells and interstitial cells were also collected for experiments.

Cell culture
------------

Mouse GS cells were originally established from mouse pups with DBA/2 background and kindly provided by Dr T Shinohara's laboratory. The culture conditions used were as described previously \[[@r17]\]. Briefly, GS cells were cultured on mitomycin C (Nacalai Tesque Inc.)-inactivated mouse embryonic feeder cells with StemPro34 SFM-based medium (Thermo Fischer Scientific) supplemented with 1% fetal bovine serum (Biowest, Nuaillé, France), 10 ng/mL rat GDNF (Peprotech, London, UK), and 10 ng/ml human FGF2 (Peprotech). Before experiments, GS cells were maintained on laminin-coated dishes (Corning, Corning, NY, USA) for more than 2 weeks and then subjected to analyses.

Quantitative reverse transcription-polymerase chain reaction (RT-qPCR)
----------------------------------------------------------------------

Total RNA was extracted using Sepasol-RNA I Super G (Nacalai Tesque). Total RNA samples were subjected to cDNA synthesis using ReverTra Ace with gDNA remover (TOYOBO, Osaka, Japan). The cDNA samples were then analyzed by RT-qPCR using SYBR Premix Ex Taq II in combination with a Thermal Cycler Dice^®^ Real Time System TP800 (TAKARA BIO Inc., Shiga, Japan). Reaction conditions were as follows: 95 °C for 1 min, followed by 40 cycles of 95°C for 15 sec, 55°C for 30 sec, and 72°C for 30 sec, further followed by a melting curve program. Each RT-qPCR cycle was run in duplicate. The cycle threshold (Ct) values were calculated by a second derivative maximum method using Thermal Cycler Dice® Real Time System Software Version 5.10 (TAKARA BIO). The standard curve method was applied to determine the absolute quantity. Standard cDNA stock for absolute quantitation was prepared from the PCR products using FastGene^TM^ Gel/PCR Extraction Kits (Nippon Genetics, Tokyo, Japan). For data evaluation, values of the control group were set to 1.0 after normalization to *Hprt* expression levels. The primers used in this study are listed in [Table 1](#tbl_001){ref-type="table"}Table 1.Primers for RT-qPCRGeneForward primerReverse primer*Acta2*CTGACAGAGGCACCACTGAACATCTCCAGAGTCCAGCACA*Aldh1a2*CCATGACTTCCAGCGAGATTCTGAGTTCTGCCATTCATTG*Cyp17a1*CGTCTTTCAATGACCGGACTCATAAACCGATCTGGCTGGT*Cyp26a1*TGACCCGCAATCTCTTCTCTGAGGAGCTCTGTTGACGATTG*Ddx4*CAGGCAATGGTGACACTTACCATGGAGTCCTCATCCTCTGG*Fgf2*CCAACCGGTACCTTGCTATGTATGGCCTTCTGTCCAGGTC*Fgfr1IIIb*CTTGCCGTATGTCCAGATCCTCACAGCTGGTCTCTCTTCC*Fgfr1IIIc*AAGCACATCGAGGTGAACGTCAACCATGCAGAGTGATGG*Fgfr2IIIb*CCACATCCAGTGGATCAAGCTCACATTGAACAGAGCCAGC*Fgfr2IIIc*CCACATCCAGTGGATCAAGCATCTCCTTCTCTCTCACAGGCG*Fgfr3IIIb*GTGTACAGCGATGCACAGCCACATTCTCACTGATCCAGG*Fgfr3IIIc*CAACCAGACAGCCATTCTAGGCATTGTGCAAGGACAGAACC*Fgfr4*CAAGTGGTTCGTGCAGAGGCATTCCACAATCACGTACAGG*Gdnf*GCCACTTGGAGTTAATGTCCCTTCGAGAAGCCTCTTACCG*Hprt*GCTGGTGAAAAGGACCTCTCACAGGACTAGAACACCTGC*Sox9*AGGAAGCTGGCAGACCAGTACGTTCTTCACCGACTTCCTC.

Histology
---------

For histological analysis, the collected testes were fixed in Bouin's solution (Sigma-Aldrich) for 12 h at 4°C. After washing with 70% ethanol, the tissues were processed for routine histology, and paraffin wax-embedded sections were stained with hematoxylin and eosin. Images were captured under a light microscope (IX73; Olympus, Tokyo, Japan) equipped with a digital camera (DP73; Olympus). The numbers of tubule cross-sections with evidence of spermatogenesis, defined as the presence of at least two layers of germ cells in the entire circumference of the tubule, were counted. Tubules with multiple germ cell layers covering only part of the seminiferous tubule were not considered to be "true" spermatogenic tubules for this analysis \[[@r26]\].

Statistical analyses
--------------------

Results are presented as the mean ± standard error of the mean (SEM). Significant differences between means for single comparisons were determined using Student's *t*-test. Multiple comparison analyses were carried out using one-way analysis of variance followed by Tukey's honest significant difference test. P \< 0.05 was considered statistically significant.

Results {#s2}
=======

Fgf2 is expressed in both germ cells and testicular somatic cells
-----------------------------------------------------------------

To identify the origin of FGF2 in the testis, we performed RT-qPCR analysis. Germ cell depletion by busulfan treatment, experimental cryptorchidism, and W mutation resulted in loss of *Ddx4* and upregulation of *Gdnf* expression in the testis ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.Identification of *Fgf2*-expressing cells and their targets in the testes. (A) RT-qPCR results: the effects of busulfan treatment (44 mg/kg body weight) on mice with a congenital spermatogenic defect (W mutation), and experimental cryptorchidism were analyzed. After normalization to *Hprt* expression level, the values of control groups (vehicle, sham, and wild-type groups for the busulfan, cryptorchid, and W groups, respectively) were set to 1.0 (n = 5--8 for each group). The testes were harvested at 4 weeks (busulfan treatment) or 7 weeks (experimental cryptorchidism) after treatment and subjected to analysis. W mouse testes were harvested at 8 weeks of age. Age-matched mice were used as control samples in each experiment. (B) Preparation of seminiferous tubules and testicular interstitium. The testes were harvested at 4 weeks after treatment with 44 mg/kg body weight busulfan (Bus testes) and subjected to collagenase digestion to separate interstitial cells (ICs) from the seminiferous tubules (Tubs). The resulting populations were subjected to RT-qPCR. (C) Gene expression of niche components. After normalization to *Hprt* expression level, the value of the "Bus testis" group was set to 1.0 (n = 6 for each group). (D) *Fgfr* expression in GS cells and niche components. The value of each sample is indicated after normalization to *Hprt* expression (n = 3 independent cultures of GS cells and n = 6 for Tubs and ICs). Results are shown as the mean ± SEM. Daggers (†) indicate statistically significant differences between treatment groups (P \< 0.05).). This is consistent with the fact that Sertoli cells produce GDNF \[[@r27],[@r28],[@r29]\]. By contrast, *Fgf2* expression was downregulated by germ cell depletion ([Fig. 1A](#fig_001){ref-type="fig"}), suggesting that germ cells are the major population that express *Fgf2.* However, we still observed considerable *Fgf2* expression in germ cell-depleted testes. For further exploring *Fgf2*-expressing cells in the testes, germ cell-depleted testes (termed "Bus testis") were divided into testicular interstitial cells (ICs) and seminiferous tubules (Tubs) by collagenase digestion ([Fig. 1B](#fig_001){ref-type="fig"}). RT-qPCR revealed that ICs were enriched in *Cyp17a1*-expressing Leydig cells \[[@r30]\], whereas Tubs were enriched in Sertoli cells and PMCs ([Fig. 1C](#fig_001){ref-type="fig"}) \[[@r31], [@r32]\]. Although ICs showed higher expression than Tubs, we found that both populations expressed *Fgf2* ([Fig. 1C](#fig_001){ref-type="fig"}).

We also explored the cellular target of FGF2 in the testes. In this experiment, we used mouse GS cells as an in vitro model of SSCs and/or undifferentiated spermatogonia. RT-qPCR revealed that both GS cells and testicular somatic cells expressed *Fgfr1* ([Fig. 1D](#fig_001){ref-type="fig"}). *Fgfr2/3/4* were also expressed in Tubs and ICs. These results suggest that FGF2 targets not only SSCs and/or undifferentiated spermatogonia but also testicular somatic cells.

Fgf2 regulation in the testis
-----------------------------

It is known that the hypothalamic-pituitary (HP) axis regulates testicular functions \[[@r33]\]. To examine the role of HP axis in the regulation of testicular *Fgf2*, we assessed the effect of functional disruption of the pituitary gland. After hypophysectomy, *Cyp17a1* \[a gene expressed in Leydig cells and regulated by luteinizing hormone (LH)\] expression was diminished just 1 week after the operation, the germ cell population gradually declined, and the testis weight decreased, as compared with that in the sham-operated group ([Fig. 2A, B](#fig_002){ref-type="fig"}Fig. 2.Mechanisms regulating *Fgf2* and *Gdnf* expression in the testes. Effects of endocrine organs and RA signaling were examined. (A and B) Effect of hypophysectomy on *Fgf2* and *Gdnf* expression in the testis. (A) Testis weight and histology. Hypophysectomized and sham-operated mouse testes were prepared for histological analysis at 1, 2, and 7 weeks post operation. Paraffin wax-embedded sections were stained with hematoxylin and eosin. Testis weights at each time point are shown in the inserts as the mean ± SEM (mg). (B) qPCR analysis. Gene expression profiles were analyzed. After normalization to *Hprt* expression, the value of the "Sham" group in each time-point was set to 1.0 (n = 3--4 for each group). (C and D) Effect of thyroidectomy on *Fgf2* and *Gdnf* expression in the testis. (C) Histological changes. Thyroidectomized and sham-operated mouse testes were prepared for histological analysis at 7 weeks post operation. Paraffin wax-embedded sections were stained with hematoxylin and eosin. (D) Effect of thyroidectomy. After normalization to *Hprt* expression, the value of the "Sham" group was set to 1.0 (sham, n = 4; thyroidectomy, n = 5). (E and F) Effect of adrenalectomy on *Fgf2* and *Gdnf* expression in the testis. (E) Histological changes. Adrenalectomized and sham-operated mouse testes were prepared for histological analysis at 7 weeks post operation. Paraffin wax-embedded sections were stained with hematoxylin and eosin. (F) Effect of adrenalectomy. After normalization to *Hprt* expression, the value of the "Sham" group was set to 1.0 (sham, n = 4; adrenalectomy, n = 5). (G) Effect of RA treatment. 8-week-old male B6 mice were injected intraperitoneally with 750 µg RA. The testes were collected 11 h after treatment, and analyzed by RT-qPCR (n = 4 for each group). Bar = 100 μm (A, C, E). Results are shown as the mean ± SEM. Daggers (†) indicate statistically significant differences between treatment groups (P \< 0.05).). These data confirmed that hypophysectomy was performed successfully. In this situation, *Fgf2* and *Gdnf* exhibited distinct expression dynamics. *Fgf2* expression was initially upregulated and then downregulated to 40% of control levels by the end of 7 weeks, suggesting that *Fgf2* expression is somehow affected by the function of the HP axis. *Aldh1a2*, *Cyp26a1,* and *Ddx4* exhibited similar expression dynamics to those of *Fgf2*. On the other hand, *Gdnf* exhibited step-wise upregulation from 1 to 7 weeks post operation ([Fig. 2B](#fig_002){ref-type="fig"}). Although the effects of adrenalectomy and thyroidectomy were examined, these interventions did not affect spermatogenesis or the expression of *Fgf2* or *Gdnf* at 7 weeks post-surgery ([Fig. 2C--F](#fig_002){ref-type="fig"}). These results demonstrated that HP axis-mediated regulation of *Fgf2* and *Gdnf* does not require the function of the thyroid or adrenal glands.

We also examined the effect of RA treatment on the expression of testicular *Fgf2*. A single intraperitoneal injection of all-trans RA at a dose of 750 μg/body to adult mice was effective to induce activation of the RA signal-related gene, *Cyp26a1*, in the testes ([Fig. 2G](#fig_002){ref-type="fig"}). In this situation, although *Gdnf* expression was downregulated, *Fgf2* expression was not affected ([Fig. 2G](#fig_002){ref-type="fig"}). Taken together, these results demonstrated that the control mechanisms of *Fgf2* in the testes are distinct from those of *Gdnf*.

Expression dynamics of Fgf2 and Gdnf in the testes
--------------------------------------------------

We compared the expression dynamics of *Fgf2* and *Gdnf* in the mouse testes under normal physiological conditions. RT-qPCR revealed that *Gdnf* expression was downregulated with age, while *Fgf2* expression remained constant ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Expression dynamics of *Fgf2* and *Gdnf* in the testes. The testes from immature (1-week-old) and adult (8- and 52-week-old) B6 mice were subjected to RT-qPCR. After normalization to *Hprt* expression, the values of each sample are indicated directly (n = 3--5 for each group). Results are shown as the mean ± SEM. Daggers (†) indicate statistically significant differences between treatment groups (P \< 0.05).). In addition, the expression dynamics of *Fgf2* under conditions of testicular regeneration were also investigated. Treatment with a low dose (15 mg/kg body weight) of busulfan permitted testicular regeneration, as diagnosed by temporary loss and subsequent recovery of testis weight and spermatogenesis ([Fig. 4A--C](#fig_004){ref-type="fig"}Fig. 4.Expression dynamics of *Fgf2* and *Gdnf* during testicular regeneration. Mice testes treated with 15 mg/kg body weight busulfan at 6 weeks of age were analyzed at the indicated time points. (A) Histological changes induced by busulfan treatment (n = 3 for each group). Asterisks (\*) indicate tubules with spermatogenic arrest. (B) Testis weight (n = 3 for each group). (C) Spermatogenic arrest caused by busulfan treatment. The proportion of tubules with active spermatogenesis was evaluated (n = 3 for each group). The total numbers of tubules counted were 1130 and 1245 for vehicle- and busulfan-treated testes, respectively. (D) Expression of *Fgf2* and *Gdnf* during testicular regeneration. After normalization to *Hprt* expression, the value of the vehicle (V) control group at each time point was set to 1.0 (n = 3 for each group); B, busulfan. Results are shown as the mean ± SEM. Bar = 100 μm (A). Daggers (†) indicate statistically significant differences between treatment groups (P \< 0.05).). Consistent with a previous report \[[@r34]\], *Gdnf* expression was upregulated temporarily and then reverted to normal levels. Although treatment-dependent upregulation of *Fgf2* expression was also observed, the time to reversion was shorter than that for *Gdnf* ([Fig. 4D](#fig_004){ref-type="fig"}).

Discussion {#s3}
==========

GDNF is essential for the maintenance and self-renewal of SSCs in the germline niche \[[@r4], [@r16]\]. Moreover, FGF2 was also shown to act as another *bona fide* self-renewal factor for SSCs *in vitro* \[[@r24]\]. These suggest that both FGF2 and GDNF regulate SSC self-renewal in the germline niche. However, our previous study showed that F-SPG are distinct from G-SPG in that they possess more differentiated characteristics (higher expression of the differentiation marker KIT, lower SSC activity); F-SPG could survive and proliferate without activation of the MAPK signaling pathway, whereas G-SPG requires MAPK activation \[[@r24]\]. To clarify these differences in the roles of FGF2 and GDNF in the testis, we examined the spatiotemporal dynamics of these factors.

Previous studies on the identification of FGF2-producing cells have yielded inconsistent results. Some studies demonstrated FGF2 production in Sertoli cells, while others demonstrated that germ cells produced this protein. Smith *et al.* detected FGF2 production in cultured rat Sertoli cells \[[@r35]\]. Mullaney and Skinner, and Tadokoro *et al.* obtained similar results \[[@r36], [@r37]\]. By contrast, Han *et al.* demonstrated germ cell production of FGF2 \[[@r38]\]. In their study, FGF2 production was detected from cellular lysates, tissue extracts, or culture supernatants using biochemical approaches (column chromatography, western blotting, or immunohistochemistry, respectively). These contrasting reports include mutual concerns in analytical methods. One of them is the culture-mediated effect. Cell culture often causes adaptation-mediated phenotypic alterations. In addition, rapid expansion of other contaminating cell populations can affect Sertoli cells *in vitro*. Another concern is the molecular characteristic of FGF2. It is well-known that FGF2 is prone to bind to heparan sulfate proteoglycans (HSPGs), which are abundant in the extracellular matrix and at the cell surface. Therefore, a biochemical approach might help detect FGF2 molecules produced ectopically and forming complexes with HSPGs on the Sertoli cell surface. Serum used in the culture medium might also provide FGF2 supplementation. Given these circumstances, we reconsidered the source of FGF2 production in the testis. For this purpose, we employed RT-qPCR to avoid false detection of ectopically produced FGF2 and demonstrated that busulfan-mediated germ cell depletion decreased *Fgf2* expression in the testis. These results suggest that Sertoli cells are not necessarily the major FGF2-producing cells, and that germ cells could be a source of FGF2. However, other possibilities remain. Busulfan treatment might affect *Fgf2* expression in the testicular somatic cells and deprivation of germ cell-derived signals (e.g. JAG1-NOTCH2 signal) might attenuate *Fgf2* expression in the testicular somatic cells \[[@r39], [@r40]\]. To assess these possibilities, we exploited mice with a congenital defect (W) and those with experimental cryptorchidism in which spermatogonia are maintained \[[@r37]\]. However, both the W mutation and cryptorchidism resulted in reduced *Fgf2* expression, as seen in the case of busulfan-mediated germ cell depletion, demonstrating that reduced expression of *Fgf2* is not caused by busulfan treatment or loss of germ cell-derived signals. Although these data strongly suggest that the germ cell population is the major source of FGF2 in the testis, it remains to be elucidated which subset of the germ cells produces FGF2. Experimental cryptorchidism-mediated decline of *Fgf2* expression suggests that differentiated germ cells rather than spermatogonia strongly express *Fgf2*. On the other hand, Zhang *et al.* demonstrated that cultured SSCs produce FGF2 \[[@r41]\]. We also found that non-germ cell populations forming seminiferous tubules and interstitial compartment in the testes showed non-negligible *Fgf2* expression. However, the actual subset of testicular somatic cells remains to be identified. The seminiferous tubules we isolated expressed not only *Sox9* but also *Acta2*, suggesting the significant enrichment of Sertoli cells and PMCs. On the other hand, the testicular interstitium was shown to be enriched in Leydig cells. Blood vessels might also be included in the interstitial compartment. To conclude, it is most appropriate to purify the subsets of testis cells using fluorescence-activated cell sorting/magnetic-activated cell sorting in combination with a reporter strain animal \[[@r42], [@r43]\].

It is well known that the HP axis regulates testicular function via the actions of follicle stimulating hormone (FSH) and LH. In addition, the thyroid and adrenal glands have been suggested to regulate testicular function in rats \[[@r44], [@r45]\]. Although thyroidectomy and adrenalectomy did not affect the expression of self-renewal factors in the testis, a gradual decrease in *Fgf2* expression was observed in hypophysectomized mice. Rapid downregulation of *Cyp17a1* expression, which is induced in Leydig cells by LH stimulus and is indispensable for testosterone synthesis, confirmed successful hypophysectomy. Considering the gradual decrease in *Ddx4* expression and rapid decrease in *Cyp17a1* expression after hypophysectomy, a decrease in *Fgf2* expression is likely because of the reduction in the *Fgf2*-expressing germ cell population*,* rather than loss of endocrine signals from the HP axis. Moreover, hypophysectomy enhanced testicular *Gdnf* expression in a step-wise manner. This upregulation of testicular *Gdnf* expression is consistent with the findings of previous reports \[[@r14], [@r46],[@r47],[@r48]\]. Considering that *Lhcgr* knockout mice, but not *Fshb* knockout mice, exhibited increased expression of *Gdnf*, pituitary gland-derived LH signals might suppress *Gdnf* expression in the testis \[[@r14]\]. It is intriguing that hypophysectomy upregulated *Gdnf* expression in a step-wise manner. We also found that *Cyp26a1* and *Aldh1a2* expression was significantly suppressed at 7 weeks after hypophysectomy. *Cyp26a1* encodes a RA-metabolizing enzyme and is induced by RA in the testes ([Fig. 2G](#fig_002){ref-type="fig"}). RA production is dependent on the germ cell-expressed enzyme encoded by *Aldh1a2* \[[@r49], [@r50]\]. Hasegawa *et al.* also demonstrated that RA treatment attenuated testicular *Gdnf* expression \[[@r51]\]. Based on these results, the upregulated expression of *Gdnf* in the second step might be due to the reduction of RA signal. Although our results regarding hypophysectomy are not consistent with those of Chen *et al.*, who found that testosterone induced GDNF production from PMCs *in vitro* \[[@r52]\], it is possible that experimental differences (*in vivovs*. *in vitro* studies) might have caused these contradictory results. On the other hand, we also found that *Fgf2* expression was not affected by RA treatment, but *Gdnf* expression was suppressed. *Gdnf* is expressed in Sertoli cells and PMCs \[[@r4], [@r5], [@r52]\]. In addition, the expression level of this gene oscillates in the seminiferous epithelial cycle \[[@r53]\]. Hogarth *et al.* demonstrated the periodic oscillatory change of RA content in the seminiferous tubule \[[@r54]\]. Hasegawa *et al*. showed that RA administration suppresses *Gdnf* expression in the testes of mice \[[@r51]\]. We also obtained similar results ([Fig. 2G](#fig_002){ref-type="fig"}). These data suggest that the oscillatory expression pattern of *Gdnf* is causally related with RA oscillations. By contrast, *Fgf2* expression was not affected by RA administration ([Fig. 2G](#fig_002){ref-type="fig"}), despite the fact that RA receptors are expressed in both germ and somatic cells, which have been demonstrated to express *Fgf2* \[[@r55]\]. Also, the HP axis might not directly contribute to the regulation of *Fgf2* in the testis ([Fig. 2B](#fig_002){ref-type="fig"}). Taken together, these data suggested that the mechanism of *Fgf2* regulation in the testis is distinct from that of *Gdnf*, raising the possibility that FGF2 and GDNF might act at different domains and/or timings in the testis.

We found that *Gdnf* expression was attenuated with aging, while strong expression of *Fgf2* in the pup testes was maintained even after the prepubertal stage. Germ cell depletion also changes the expression pattern of these genes, in that *Fgf2* expression is decreased, while *Gdnf* expression is increased ([Fig. 1A](#fig_001){ref-type="fig"}). *Gdnf/Fgf2* ratio in the testes seems higher in the prepubertal stages and germ cell-deficient conditions, as compared to that in normal adult testes. Given that the expression mechanism of *Fgf2* is distinct from that of *Gdnf*, these genes should exhibit differential expression patterns in the testis. Our previous study demonstrated that F-SPG exhibited more differentiated characteristics than G-SPG \[[@r24]\]. These observations raise the possibility that fluctuation in the *Gdnf/Fgf2* ratio along the seminiferous tubule might affect the action of SSCs and/or undifferentiated spermatogonia in the germline niche.

Our previous report demonstrated that FGF2 contributes to maintaining the SSC activity of GS cells and F-SPG, both of which express genes encoding FGF2 receptors \[[@r17], [@r24]\], suggesting that SSCs *in vivo* can be a target of this molecule. In this study, we also found that testicular somatic cells express *Fgfr* genes, raising the possibility that FGF2 might act on these cells. Somatic cells in the tubules (Sertoli cells and PMCs) express *Gdnf* \[[@r4], [@r5], [@r52]\]. Leydig cells are reported to produce CSF1 \[[@r8], [@r9]\]. Germ cell- and/or testicular somatic cell-derived FGF2 might regulate the self-renewal of SSCs *in vivo* not only in a direct manner, but also in an indirect manner by regulating the expression of self-renewal factors in the germline niche. On the other hand, these somatic cells simultaneously contribute to the synthesis and metabolism of RA \[[@r55], [@r56]\]. Therefore, FGF2 might also contribute to the regulation of RA action in the testis for proper spermatogenesis.

We exploited low-dose busulfan administration as a model for testicular regeneration \[[@r34], [@r57]\]. Although high-dose busulfan might also induce regeneration, we thought that it would be better to avoid complete destruction of the germ cell population to reproduce the process of testicular regeneration precisely. This procedure results in testicular regeneration within 70 days \[[@r57]\]. Upon treatment, both factors exhibited temporal upregulation, raising the possibility that these factors contribute to regenerative action in the testis. Although both germ cells and testicular somatic cells can contribute to this action, we did not identify which population contributed to the upregulation of *Fgf2* expression in the testis under regenerative conditions. To understand the mechanism of *Fgf2* regulation in the testis, both identification of FGF2-producing cells and molecular dissection of the *Fgf2*-expressing mechanisms in each cell type are required.

Although both FGF2 and GDNF are *bona fide* self-renewal factors for SSCs *in vitro*, FGF2 provides outcomes for cultured undifferentiated spermatogonia that are distinct from those provided by GDNF *in vitro* (e.g., SSC frequency and expression of differentiation markers) \[[@r24]\]. These data suggest that FGF2 plays a role that is distinct from that of GDNF in the germline niche. Our present study also supports this idea by raising the possibility that FGF2 and GDNF act at different times and/or regions in the testis. This study suggests the existence of functionally distinct "FGF2-dominant niche" and "GDNF-dominant niche". The former might permit spermatogonial differentiation in the adult testes and the latter might contribute to expansion of undifferentiated spermatogonia in the prepubertal stages and during testicular regeneration. Moreover, these niches might change their domain size depending on the developmental/aging stage, seminiferous epithelial cycle, and ectopic cues, such as testicular damage. The next issue to be clarified is how the spatiotemporal balance of action of these factors is regulated.
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